Industry

　As Pulsed Field Ablation (PFA) is rapidly being adopted for the treatment of atrial fibrillation, its non-thermal ablation mechanism—based on irreversible electroporation—has significantly improved both safety and procedural efficiency. However, critical challenges remain in product development and mass production. In this context, Nextron has leveraged its long-standing expertise in Radiofrequency (RF) ablation and Cryoablation, while swiftly advancing its focus on PFA solutions. By integrating these three ablation technologies, Nextron is building a comprehensive Electrophysiology (EP) solution portfolio.

　First, the kV-level high-voltage pulses and microsecond (µs)-scale transient discharges required by PFA impose stringent demands on high-voltage transient electric field shaping, insulation design, and overall system stability. In addition, compliance with medical-grade standards such as ISO 13485, along with long-term reliability validation and international regulatory requirements, significantly raises the barriers to development and large-scale manufacturing.

　To meet the application requirements of PFA systems, Nextron offers customized high-voltage interconnect solutions compliant with IEC 60664-4 standards (2000–5000 VDC). These solutions enable stable transmission of high-voltage pulses and precise energy control within limited space, while balancing insulation safety and miniaturized mechanical design. They have already been successfully integrated into systems from multiple PFA device manufacturers, demonstrating Nextron’s reliability and engineering maturity in high-voltage medical connectivity.

 

What are the key technologies of Pulsed Field Ablation (PFA)?

　Pulsed Field Ablation (PFA) has rapidly emerged in the treatment of cardiac arrhythmias—particularly atrial fibrillation—not because it relies on heating or freezing, but because it directly uses electric fields to act on the cells themselves. At its core, several key technological pillars support this approach.

　As a new-generation non-thermal ablation technology, PFA induces cell disruption indirectly, offering higher safety and shorter procedure times. It has quickly become a focal point of competition in the market.

	PFA	RF	CRYO
Ablation mechanism	Using kV-level high-voltage pulsed electric fields to induce irreversible electroporation, thereby disrupting the cell membrane.	Ablating tissue by generating heat through high-frequency current (Joule heating).	Rapidly cooling tissue using a refrigerant (such as liquid N₂O) to induce freezing, leading to cell necrosis.
Mode of tissue disruption	Cell membrane electroporation → cell apoptosis	Thermal coagulative necrosis	Intracellular ice crystal formation → cell rupture
Key advantages	Non-thermal damage High safety Rapid operation	Technologically mature Broad range of indications Widely adopted equipment	High success rate Short learning curve Stable lesion formation

What are the key design considerations for PFA?

＂The true key of PFA is not simply “electricity,” but rather how to use a precisely controlled electric field to selectively ablate cardiomyocytes while sparing surrounding tissues.＂

　Although electrophysiology technologies have gradually matured and Pulsed Field Ablation (PFA) has demonstrated strong clinical potential, significant challenges remain in real-world adoption and large-scale manufacturing. These challenges span the implementation of multiple critical technologies across three major domains: biophysics, engineering design, and materials and process integration.

Key biophysical parameters：

　The kV-level voltage and microsecond (µs) pulses in PFA are not merely design parameters—they directly define the biophysical boundary conditions that determine whether a treatment is effective. They dictate whether the electric field can transition from “ineffective stimulation” to “therapeutic efficacy.” Only when the electric field strength and pulse duration fall within a specific range can irreversible electroporation be reliably induced, enabling effective ablation while avoiding thermal damage.

Key parameters	Technical essence	Why it is important	Design challenges
kV-level voltage	Electric field strength	Reach the critical threshold for cell membrane breakdown	Insulation design Arcing control
microsecond (µs)-scale pulses	Ultra-short-duration discharge	Low energy, avoidance of thermal effects, and reduction of parasitic inductance	Voltage and current switching transients: may lead to insulation breakdown Incorrect electric field distribution: results in poor electroporation performance (overshoot / undershoot)

Key aspects of engineering design:

　In Pulsed Field Ablation (PFA) systems, the precise control of kV-level voltage and microsecond (µs)-scale pulses directly determines whether irreversible electroporation can be reliably achieved. As designs are constrained by catheter miniaturization and procedural safety requirements, high-voltage transmission, signal integrity, and insulation architecture have become critical engineering factors that influence energy distribution and ablation performance.

　Under these conditions, manufacturing is no longer merely a support for mass production—it becomes an integral part of the design itself. Leveraging its expertise in precision interconnects and electromechanical integration, Nextron has established end-to-end capabilities spanning high-voltage transmission, cable integration, and automation deployment. This allows Nextron to engage in key design stages early in development, helping electrophysiology systems achieve an optimal balance between performance, structural constraints, and manufacturability, while accelerating time-to-market.

 

Key aspects of materials and process integration：

　In Pulsed Field Ablation (PFA) systems, the combination of kV-level high voltage and microsecond (µs) pulse characteristics means that materials and processes affect not only structural reliability, but also directly impact electric field stability and insulation safety. Suppressing charge accumulation and preventing partial discharge and arcing have therefore become critical design challenges in material selection and process integration.

　To address these challenges, insert molding technologies optimized specifically for PFA, together with precision potting processes, are used to achieve integrated interconnect structures and high-accuracy terminal positioning. Combined with high dielectric strength, medical-grade materials, these approaches effectively enhance insulation stability and long-term reliability. While meeting stringent safety and performance requirements, they also help reduce potential design risks and improve manufacturability for mass production.

 

Products：

Ｐseries

Further Reading：

Medical High-Voltage Connector Solutions: PFA and IVL Technologies

Cardiac Electrophysiology: A Look into Ablation Techniques